Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer

Cancer

Volumn 110, Issue 4, 2007, Pages 906-910

  Mouraviev, Vladimir ^a   Mayes, Janice M ^a   Sun, Leon ^a   Madden, John F ^a   Moul, Judd W ^a   Polascik, Thomas J ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Galil Medical ^*

Author keywords

Cryoablation; Focal therapy; Prostate neoplasm; Tumor laterality

Indexed keywords

PARAFFIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CATHETER ABLATION; CONTROLLED STUDY; DISEASE SEVERITY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE;

ADULT; AGED; BIOPSY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 34547856623     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22858     Document Type: Article

References (14)

1. Mouraviev V, Polascik TJ. Evolution of Whole Gland Cryosurgery to Focal Ablative Therapy for the Treatment of Localized Prostate Cancer Using Third Generation Cryotechnology. Issues in Urology, 2007:in press
2. Bahn DK, Silverman P, Lee F Sr, Badalament R, Bahn ED, Rewcastle JC. Focal prostate cryoablation: initial results show cancer control and potency preservation. J Endourol. 2006;20:688-692.
3. Akduman B, Barqawi AB, Crawford ED. Minimally invasive surgery in prostate cancer: current and future perspectives. Cancer J. 2005;11:355-361.
4. Barqawi A, Crawford ED. Focal therapy in prostate cancer: future trends. BJU Int. 2005;95:273-274.
5. Cheng L, Jones TD, Pan CX, Barbarin A, Eble JN, Koch MO. Anatomic distribution and pathologic characterization of small-volume prostate cancer (<0.5 ml) in whole-mount prostatectomy specimens. Mod Pathol. 2005;18:1022-1026.
6. Onik G, Narayan P, Vaughan D, Dineen M, Brunelle R. Focal "nerve-sparing" cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urology. 2002;60:109-114.
7. Ohori M, Eastham JA, Koh H, Kuroiwa K, Slawin K, Wheeler TM, et al.: Is focal therapy reasonable in patients with early stage prostate cancer (CAP)-an analysis of radical prostatectomy (RP) specimens. J Urol. 2006;175(suppl):507. (Abstract 1574)
8. Masson P, Prepelica K, Lambert EH, McKiernan JM, Benson MC, Olsson CA, et al. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. J Urol. 2005;173(suppl.):179.
9. Davidson PJ. Diagnosis, prognosis and management of incidentally found prostate cancer. Urol Res. 1993;21:1-8.
10. Hoedemaeker RF, Rietbergen JB, Kranse R, Schroder FH, van der Kwast TH. Histopathological prostate cancer characteristics at radical prostatectomy after population-based screening. J Urol. 2000;164:411-415.
11. Boccon-Gibod LM, Dumonceau O, Toublanc M, Ravery V, Boccon-Gibon LA. Micro-focal prostate cancer: a comparison of biopsy and radical prostatectomy specimen features. Eur Urol. 2005;48:895-899.
12. Epstein JI, Sanderson H, Carter HB, Scharfstein DO. Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy. Urology. 2005;66:356-360.
13. Boccon-Gibod LM, de Longchamps NB, Toublanc M, Boccon-Gibod LA, Ravery V. Prostate saturation biopsy in the reevaluation of microfocal prostate cancer. J Urol. 2006;176:961-963.
14. Patel U. TRUS and prostate biopsy: current status. Prostate Cancer Prostatic Dis. 2004;7:208-210.